GEUSENS, Piet

Email Alert RSS Feed

Profile

Full Name
GEUSENS, Piet
Email
piet.geusens@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 321-340 of 446 (Search time: 0.004 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
3212003Nieuwe inzichten in de relatie tussen botweefsel en ontsteking: het voorbeeld van reumatoïde artritisGEUSENS, Piet; Lems, W.; Landewé, R.Journal ContributionA3
3222003Risedronate once a week: a viewpointGEUSENS, PietJournal ContributionA3
3232003High incidence of hepatotoxicity of isoniazid treatment for tuberculosis chemoprophylaxis in patients with rheumatoid arthritis treated with methotrexate or sulfasalazine and antitumour necrosis factor inhibitorsVANHOOF, Johan; Landewe, S; Van Wijngaerden, E; GEUSENS, PietJournal ContributionA1
3242003Serum levels of receptor activator of nuclear factor kappa-beta (RANK)-ligand (L) and osteoprotegerin (OPG) independently predict long-term radiographic progression in patients with early rheumatoid arthritis (RA)Boers, M; Van der Linden, S; Garnero, P; Landewe, R; GEUSENS, Piet; VAN DER HEIJDE, Desiree; LINSEN, LoesJournal ContributionM
3252003Double-blind comparison of etanercept and sulfasalazine, alone and combined in active RA patientsCodreanu, C; Combe, B; Fiocco, U; Gaubitz, M; Kvien, T; Pavelka, K; Sambrook, P; Smolen, J; Williams, BD; Appel, A.M.; GEUSENS, PietJournal ContributionM
3262003Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of ageBraam, L.A.J.L.M.; Knapen, M.H.J.; GEUSENS, Piet; Brouns, F.; Hamulyák, K.; Gerichhausen, M.J.W.; Vermeer, C.Journal ContributionA1
3272003Biochemical markers of joint tissue turnover in early rheumatoid arthritisGarnero, P; GEUSENS, Piet; Landewe, RJournal ContributionA1
3282003Clinical use of a simple risk tool can improve case-finding for osteoporosisGEUSENS, Piet; Pols, H; Melton, M; Hochberg, MC; van der Voort, D; van der Klift, M; Ross, PDJournal ContributionM
3292003Interaction between falls and clinical fractures.GEUSENS, PietJournal ContributionM
3302003Risk of gastrointestinal events with bisphosphonates: Rating the evidenceGEUSENS, Piet; Rizzoli, R; Sambrook, P; Schnitzer, TJournal ContributionM
3312003Greater increases in bone mineral density with alendronate compared to raloxifene: Results from effect-internationalSambrook, P; Ferrer-Barriendos, J; Ribot, C; Solimano, JA; Verbruggen, N; Gaines, K; Melton, ME; GEUSENS, PietJournal ContributionM
3322003Femoral neck mechanical quality and MR microscopic Imaging of a postmenopausal osteoporosis model in ewes treated with calcitonin.Jiang, Y; Zhao, JJ; Lynch, JA; Ouyang, X; Azria, M.; Genant, HK; GEUSENS, Piet; ADRIAENSENS, Peter; GELAN, JanJournal ContributionM
3332003Factors affecting bone loss in female endurance athletes - A two-year follow-up studyBraam, L.A.J.L.M.; Knapen, M.H.J.; GEUSENS, Piet; Brouns, F.; Vermeer, C.Journal ContributionA1
142003An exceptional radiographic presentation of bilateral insufficiency fractures of the proximal tibia in a patient with rheumatoid arthritisVANHOOF, Johan; Landewe, S; VANDEVENNE, Jan; GEUSENS, PietJournal ContributionA1
152003Efficacy of Fosamax vs. evista comparison trial (effect-international): Results at 6 monthsSambrook, P; GEUSENS, Piet; Keraudren, V; Gaines, K; Leung, A; Melton, MJournal ContributionM
162003Review of guidelines for testing and treatment of osteoporosisGEUSENS, PietJournal ContributionA2
172002Osteoporosis and the growth hormone-insulin-like growth factor axisGEUSENS, Piet; Boonen, SJournal ContributionA1
182002Short-term reduction in urinary CTX-II, a marker of cartilage degradation, predicts long-term radiological progression in patients with rheumatoid arthritis (RA) treated with disease-modifying antirheumatic therapy (DMARD).Gamero, P; Landewe, RBM; Boers, M; Christgau, S; van der Linden, SJ; VAN DER HEIJDE, Desiree; GEUSENS, PietJournal ContributionM
192002Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis - The COBRA StudyGarnero, P; Landewe, R; Boers, M; Verhoeven, A; van der Linden, S; Christgau, S; Boonen, A; VAN DER HEIJDE, Desiree; GEUSENS, PietJournal ContributionA1
202002Receptor activator of the nuclear factor kappa-b ligand (RANKL) in the serum of patients with RA is strongly coupled to rheumatoid-factor presence, and predicts long-term radiologic progression.GEUSENS, Piet; Landewe, R; Dunstan, C; Gaenero, P; van der Linden, S; Boers, MJournal ContributionM
show all